Metsera After the Pfizer Deal: Which Obesity Drugs Survived
Metsera: where it is in development, what the trials show so far, and when it could reach patients.
Metsera drugs at a glance
Placebo-adjusted weight loss, as a percent of body weight, at 28 weeks (MET-097i Phase 2b)
Sources: pfizer.com.